Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 9545222.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Staphylococcus aureus causes pathologies ranging from minor skin infections to life-threatening diseases. Pathogenic effects are largely due to production of bacterial toxin, which is regulated by an RNA molecule, RNAIII. The S. aureus protein called RAP (RNAIII activating protein) activates RNAIII, and a peptide called RIP (RNAIII inhibiting peptide), produced by a nonpathogenic bacteria, inhibits RNAIII. Mice vaccinated with RAP or treated with purified or synthetic RIP were protected from S. aureus pathology. Thus, these two molecules may provide useful approaches for the prevention and treatment of diseases caused by S. aureus.
Medical subject headings
- Bacterial Proteins
- Bacterial Vaccines
- Oligopeptides
- Staphylococcal Skin Infections
- Staphylococcus aureus